Barclays plc ADR (NYSE:BCS) saw a downside of -0.52% to close Monday at $7.62 after subtracting -$0.04 on the day. The 5-day average trading volume is 9,034,700 shares of the company’s common stock. It has gained $8.03 in the past week and touched a new high 2 times within the past 5 days. An average of 8,322,795 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 8,873,596.
BCS’s 1-month performance is 3.96% or $0.28 on its low of $7.34 reached on 09/08/23. The company’s shares have touched a 52-week low of $5.89 and high of $9.44, with the stock’s rally to the 52-week high happening on 02/09/23. YTD, BCS has lost -2.31% or -$0.18 and has reached a new high 15 times. However, the current price is down -19.24% from the 52-week high price.
Valuation Metrics
BCS stock has a beta of 1.37. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.95 while the price-to-book (PB) in the most recent quarter is 0.43.
The firm’s gross profit as reported stood at $30.87 billion against revenue of $30.87 billion.
Let’s look briefly at Barclays plc ADR (BCS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 25 September was 44.42% to suggest the stock is trending Neutral, with historical volatility in this time period at 19.27%.
The stock’s 5-day moving average is $7.75, reflecting a -3.05% or -$0.24 change from its current price. BCS is currently trading +3.81% above its 20-day SMA, -1.93% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -6.62% and SMA200 by-2.43%.
Stochastic %K and %D was 45.86% and 56.58% and the average true range (ATR) pointed at 0.15. The RSI (14) points at 47.54%, while the 14-day stochastic is at 39.72% with the period’s ATR at 0.15. The stock’s 9-day MACD Oscillator is pointing at -0.16 and -0.05 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Barclays plc ADR (NYSE: BCS), Exane BNP Paribas downgraded it to a Neutral rating. They previously had an Outperform rating on the stock. Analysts offering their rating for BCS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate BCS as a “sell,”, while 8 advise that investors “Hold.” 1 analysts have rated the stock as underweight. 0 rates the stock as overweight while 9 have offered a “buy” rating.
What is BCS’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $8.74 and a high of $16.45, with their median price target at $10.38. Looking at these predictions, the average price target given by analysts is for Barclays plc ADR (BCS) stock is $11.09.
